Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Tanner, CM"" wg kryterium: Autor


Tytuł:
Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants.
Autorzy:
Wang C (AUTHOR)
Cai Y (AUTHOR)
Zheng Z (AUTHOR)
Tang BS (AUTHOR)
Xu Y (AUTHOR)
Wang T (AUTHOR)
Ma J (AUTHOR)
Chen SD (AUTHOR)
Langston JW (AUTHOR)
Tanner CM (AUTHOR)
Chan P (AUTHOR)
Chinese Parkinson Study Group (CPSG) (CORPORATE AUTHOR)
Wang, Chaodong (AUTHOR)
Cai, Yanning (AUTHOR)
Zheng, Zheng (AUTHOR)
Tang, Bei-Sha (AUTHOR)
Xu, Yanming (AUTHOR)
Wang, Tao (AUTHOR)
Ma, Jinghong (AUTHOR)
Chen, Sheng-Di (AUTHOR)
Pokaż więcej
Źródło:
Parkinsonism & Related Disorders. Sep2012, Vol. 18 Issue 8, p958-963. 6p.
Czasopismo naukowe
Tytuł:
Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram.
Autorzy:
Karabayir I; Cardiovascular Section, Department of Internal Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
Gunturkun F; Quantitative Sciences Unit, Department of Medicine, Stanford University, Palo Alto, CA, USA.
Butler L; Cardiovascular Section, Department of Internal Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
Goldman SM; Division of Occupational, Environmental, and Climate Medicine, San Francisco Veterans Affairs Medical Center, University of California-San Francisco, 4150 Clement Street, Box 127, San Francisco, CA, 94121, USA. .
Kamaleswaran R; Department of Biomedical Informatics, Emory University, Atlanta, GA, USA.
Davis RL; Center for Biomedical Informatics, University of Tennessee Health Science Center, Memphis, USA.
Colletta K; Department of Neurology, Edward Hines Jr. VA Hospital, Hines, IL, USA.
Chinthala L; Center for Biomedical Informatics, University of Tennessee Health Science Center, Memphis, USA.
Jefferies JL; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Bobay K; Parkinson School of Health Sciences and Public Health, Loyola University Chicago, Maywood, IL, USA.
Ross GW; Veterans Affairs Pacific Islands Health Care Systems, Honolulu, HI, USA.
Petrovitch H; Pacific Health Research and Education Institute, Honolulu, HI, USA.
Masaki K; Kuakini Medical Center, Honolulu, HI, USA.; Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Akbilgic O; Cardiovascular Section, Department of Internal Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jul 29; Vol. 13 (1), pp. 12290. Date of Electronic Publication: 2023 Jul 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Deep Learning*
Parkinson Disease*/diagnosis
Humans ; Artificial Intelligence ; Case-Control Studies ; Prodromal Symptoms ; Electrocardiography
Czasopismo naukowe
Tytuł:
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
Autorzy:
Patterson CG; Department of Physical Therapy, University of Pittsburgh, School of Health and Rehabilitation Sciences, 100 Technology Drive, Suite 500, Pittsburgh, PA, 15219, USA. .
Joslin E; Department of Physical Therapy and Human Science, Northwestern University, Feinberg School of Medicine, Suite 1100, 645 North Michigan Avenue, Chicago, IL, 60305, USA.
Gil AB; Department of Physical Therapy, University of Pittsburgh, School of Health and Rehabilitation Sciences, 100 Technology Drive, Suite 500, Pittsburgh, PA, 15219, USA.
Spigle W; Department of Physical Therapy, University of Pittsburgh, School of Health and Rehabilitation Sciences, 100 Technology Drive, Suite 500, Pittsburgh, PA, 15219, USA.
Nemet T; Department of Physical Therapy, University of Pittsburgh, School of Health and Rehabilitation Sciences, 100 Technology Drive, Suite 500, Pittsburgh, PA, 15219, USA.
Chahine L; Department of Neurology, University of Pittsburgh, School of Medicine, 3471 Fifth Avenue, Pittsburgh, PA, 15213, USA.
Christiansen CL; Department of Physical Medicine & Rehabilitation, University of Colorado, School of Medicine, Aurora, CO, 80217, USA.
Melanson E; Division of Endocrinology, Metabolism and Diabetes, and Division of Geriatric Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Eastern Colorado VA Health Care System, Geriatric Research Education and Clinical Center (GRECC), Denver, CO, USA.
Kohrt WM; Division of Geriatric Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Eastern Colorado Geriatric Research, Education, and Clinical Center, Rocky Mountain Regional VAMC, Aurora, USA.
Mancini M; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Road, Portland, OR, 97219, USA.
Josbeno D; Department of Physical Therapy, University of Pittsburgh, School of Health and Rehabilitation Sciences, 100 Technology Drive, Suite 500, Pittsburgh, PA, 15219, USA.
Balfany K; Department of Physical Medicine & Rehabilitation, University of Colorado, School of Medicine, Aurora, CO, 80217, USA.
Griffith G; Department of Physical Therapy and Human Science, Northwestern University, Feinberg School of Medicine, Suite 1100, 645 North Michigan Avenue, Chicago, IL, 60305, USA.
Dunlap MK; Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Lamotte G; Movement Disorders Division, Department of Neurology, University of Utah, 175 Medical Dr N, Salt Lake City, UT, 84132, USA.
Suttman E; Department of Physical Therapy & Athletic Training, University of Utah, 520 Wakara Way, Salt Lake City, UT, 84115, USA.
Larson D; Department of Neurology, Feinberg School of Medicine, Northwestern University, Suite 115, 710 N Lake Shore Drive, Chicago, IL, 60611, USA.
Branson C; Morehouse School of Medicine, 720 Westview Dr SW, Atlanta, GA, 30310, USA.
McKee KE; Neurosciences Clinical Program, Intermountain Healthcare, 5171 S Cottonwood Street, Suite 810, Murray, UT, 84107, USA.
Goelz L; Department of Kinesiology and Nutrition, UIC College of Applied Health Sciences, 919 W Taylor Street, Chicago, IL, 60612, USA.
Poon C; Department of Neurology, Feinberg School of Medicine, Northwestern University, Suite 115, 710 N Lake Shore Drive, Chicago, IL, 60611, USA.
Tilley B; Department of Biostatistics and Data Science, University of Texas Health Science Center School of Public Health, 1200 Pressler Street E835, Houston, TX, 77030, USA.
Kang UJ; NYU Langone Health, NYU Grossman School of Medicine, 435 E 30th Street, Science Building 1305, New York, NY, 10016, USA.
Tansey MG; Department of Neuroscience and Neurology, Normal Fixel Institute for Neurological Diseases and College of Medicine, University of Florida, 4911 Newell Road, Gainesville, FL, 32610, USA.
Luthra N; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, 1651 4th Street, San Francisco, CA, 94158, USA.
Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, 1651 4th Street, San Francisco, CA, 94158, USA.
Haus JM; School of Kinesiology, University of Michigan, 830 N. University Ave, Ann Arbor, MI, 48109, USA.
Fantuzzi G; Department of Kinesiology and Nutrition, UIC College of Applied Health Sciences, 919 W Taylor Street, Chicago, IL, 60612, USA.
McFarland NR; Department of Neurology, Norman Fixel Institute for Neurological Diseases, College of Medicine, University of Florida, Gainesville, FL, 32608, USA.
Gonzalez-Latapi P; Department of Neurology, Feinberg School of Medicine, Northwestern University, Suite 115, 710 N Lake Shore Drive, Chicago, IL, 60611, USA.
Foroud T; Department of Medical and Molecular Genetics, Indiana University School of Medicine, 410 W. 10th Street, Indianapolis, IN, 46220, USA.
Motl R; Department of Kinesiology and Nutrition, UIC College of Applied Health Sciences, 919 W Taylor Street, Chicago, IL, 60612, USA.
Schwarzschild MA; Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, Rm 3002, 114 16th Street, Boston, MA, 02129, USA.
Simuni T; Department of Neurology, Feinberg School of Medicine, Northwestern University, Suite 115, 710 N Lake Shore Drive, Chicago, IL, 60611, USA.
Marek K; Institute for Neurodegenerative Disorders, 60 Temple St, New Haven, CT, 06510, USA.
Naito A; Parkinson's Foundation 200 SE 1st Street Suite 800, Miami, FL, 33131, USA.
Lungu C; National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Blvd, #2188, Rockville, MD, 20852, USA.
Corcos DM; Department of Physical Therapy and Human Science, Northwestern University, Feinberg School of Medicine, Suite 1100, 645 North Michigan Avenue, Chicago, IL, 60305, USA.
Pokaż więcej
Corporate Authors:
SPARX3-PSG Investigators
Źródło:
Trials [Trials] 2022 Oct 06; Vol. 23 (1), pp. 855. Date of Electronic Publication: 2022 Oct 06.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Parkinson Disease*/diagnosis
Parkinson Disease*/drug therapy
Antiparkinson Agents/therapeutic use ; Brain-Derived Neurotrophic Factor ; C-Reactive Protein ; Clinical Trials, Phase III as Topic ; Dopamine Plasma Membrane Transport Proteins/therapeutic use ; Exercise ; Exercise Therapy/methods ; Humans ; Multicenter Studies as Topic ; Quality of Life ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.
Autorzy:
Picillo M; Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry, Neuroscience Section, University of Salerno, Italy.
LaFontant DE; Department of Biostatistics, The University of Iowa, Iowa City, IA, USA.
Bressman S; Department of Neurology, Icahn School of Medicine at Mount Sinai and Mount Sinai Beth Israel, New York, NY, USA.
Caspell-Garcia C; Department of Biostatistics, The University of Iowa, Iowa City, IA, USA.
Coffey C; Department of Biostatistics, The University of Iowa, Iowa City, IA, USA.
Cho HR; Department of Biostatistics, The University of Iowa, Iowa City, IA, USA.
Burghardt EL; Department of Biostatistics, The University of Iowa, Iowa City, IA, USA.
Dahodwala N; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Saunders-Pullman R; Department of Neurology, Icahn School of Medicine at Mount Sinai and Mount Sinai Beth Israel, New York, NY, USA.
Tanner CM; Weill Institute for Neuroscience, Department of Neurology, University of California-San Francisco, & Parkinson's Disease Research Education and Clinical Center, San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA.
Amara AW; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Pokaż więcej
Corporate Authors:
Parkinson’s Progression Markers Initiative
Źródło:
Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (1), pp. 421-436.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biological Products*
Parkinson Disease*/cerebrospinal fluid
Parkinson Disease*/diagnosis
Biomarkers/cerebrospinal fluid ; Disease Progression ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł:
Surveying Global Availability of Parkinson's Disease Treatment.
Autorzy:
Goh ZHK; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Cheong JLY; Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Marras C; Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Research, Toronto Western Hospital, Toronto, Ontario, Canada.
Tanner CM; Department of Neurology, Weill Institute for Neuroscience University of California - San Francisco, and Parkinson's Disease Research Education and Clinical Center, San Francisco Veteran's Affairs Medical Center, San Francisco, CA, USA.
Kasten M; Institute of Neurogenetics, University of Lübeck, Germany.
Korczyn AD; Department of Neurology, Tel Aviv University, Israel.
Chahine L; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
Lo R; Memory and Aging Center, Department of Neurology, Buddhist Tzu Chi General Hospital, and Tzu Chi University, Hualien, Taiwan.
Noyce AJ; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, UK.
Pokaż więcej
Corporate Authors:
Movement Disorders Society Epidemiology Study Group
Źródło:
Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (3), pp. 1023-1034.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neurodegenerative Diseases*
Parkinson Disease*/therapy
Humans ; Income ; Quality of Life ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables.
Autorzy:
Karabayir I; Loyola University Chicago, Maywood, IL, USA.; Kirklareli University, Kirklareli, Turkey.
Butler L; Loyola University Chicago, Maywood, IL, USA.
Goldman SM; University of California San Francisco, San Francisco, CA, USA.; San Francisco VA Health Care System, San Francisco, CA, USA.
Kamaleswaran R; Emory University, Atlanta, GA, USA.; Georgia Institute of Technology, Atlanta, GA, USA.
Gunturkun F; University of Tennessee Health Sciences Center, Memphis,, TN, USA.
Davis RL; University of Tennessee Health Sciences Center, Memphis,, TN, USA.
Ross GW; Veterans Affairs Pacific Islands Health Care System, Honolulu, HI, USA.; Department of Geriatric Medicine, University of Hawaii, Honolulu, HI, USA.
Petrovitch H; Veterans Affairs Pacific Islands Health Care System, Honolulu, HI, USA.; Department of Geriatric Medicine, University of Hawaii, Honolulu, HI, USA.
Masaki K; Department of Geriatric Medicine, University of Hawaii, Honolulu, HI, USA.; Kuakini Medical Center, Honolulu, HI, USA.
Tanner CM; University of California San Francisco, San Francisco, CA, USA.; San Francisco VA Health Care System, San Francisco, CA, USA.
Tsivgoulis G; University of Tennessee Health Sciences Center, Memphis,, TN, USA.
Alexandrov AV; University of Tennessee Health Sciences Center, Memphis,, TN, USA.
Chinthala LK; University of Tennessee Health Sciences Center, Memphis,, TN, USA.
Akbilgic O; Wake Forest School of Medicine, Winston-Salem, NC, USA.
Pokaż więcej
Źródło:
Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (1), pp. 341-351.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Parkinson Disease*/diagnosis
Parkinson Disease*/pathology
Humans ; Machine Learning ; Prodromal Symptoms ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Recruitment for Remote Decentralized Studies in Parkinson's Disease.
Autorzy:
Myers TL; Center for Health, +, Technology, University of Rochester, Rochester, NY, USA.
Augustine EF; Center for Health, +, Technology, University of Rochester, Rochester, NY, USA.; Kennedy Krieger Institute, Baltimore, MD, USA.
Baloga E; Center for Health, +, Technology, University of Rochester, Rochester, NY, USA.
Daeschler M; Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
Cannon P; 23andMe, Inc., Sunnyvale, CA, USA.
Rowbotham H; 23andMe, Inc., Sunnyvale, CA, USA.
Chanoff E; 23andMe, Inc., Sunnyvale, CA, USA.
Jensen-Roberts S; Center for Health, +, Technology, University of Rochester, Rochester, NY, USA.
Soto J; Center for Health, +, Technology, University of Rochester, Rochester, NY, USA.
Holloway RG; Department of Neurology, University of Rochester, Rochester, NY, USA.
Marras C; The Edmond J Safra Program in Parkinson's disease, University Health Network, University of Toronto, Toronto, ON, Canada.
Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.; PADRECC, San Francisco VAMC, San Francisco, CA, USA.
Dorsey ER; Center for Health, +, Technology, University of Rochester, Rochester, NY, USA.; Department of Neurology, University of Rochester, Rochester, NY, USA.
Schneider RB; Center for Health, +, Technology, University of Rochester, Rochester, NY, USA.; Department of Neurology, University of Rochester, Rochester, NY, USA.
Pokaż więcej
Corporate Authors:
23andMe Research Team
Źródło:
Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (1), pp. 371-380.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Parkinson Disease*/therapy
Patient Selection*
COVID-19 ; Cross-Sectional Studies ; Humans ; Longitudinal Studies ; Pandemics
Czasopismo naukowe
Tytuł:
Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and Dyskinesia.
Autorzy:
Mehta SH; Department of Neurology, Mayo Clinic-Scottsdale, 13400 East Shea Blvd, Scottsdale, AZ, 85254, USA. .
Pahwa R; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Tanner CM; Department of Neurology, University of California, San Francisco, CA, USA.
Hauser RA; USF Parkinson's Disease and Movement Disorders Center Parkinson Foundation Center of Excellence, University of South Florida, Tampa, FL, USA.
Johnson R; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.
Pokaż więcej
Źródło:
Neurology and therapy [Neurol Ther] 2021 Jun; Vol. 10 (1), pp. 307-320. Date of Electronic Publication: 2021 Apr 17.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies